Bristol Myers Squibb is restructuring its research and development organization under Cristian Massacesi as chief research officer Robert Plenge prepares to exit.
Bristol Myers Squibb is restructuring its R&D leadership as its research chief departs and scientific and clinical teams merge under a single executive.